Atnaujinkite slapukų nuostatas

El. knyga: Difficult Decisions in Thoracic Surgery: An Evidence-Based Approach

Kitos knygos pagal šią temą:
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

As the complexity of decision-making in medicine, and surgery in particular, is growing exponentially, this book provides a practical guide to decision-making in thoracic surgery. It offers guidance on how to select among the varied and complex approaches that new technology provides. Concise and easy to follow chapters are devoted to one or two specific questions or decisions in thoracic surgery, aiding the reader to develop their decision-making skills.





Difficult Decisions in Thoracic Surgery offers clearly formatted and evidence-based chapters to help the reader navigate the complexities of thoracic surgery. All new chapters bring insight into the challenges faced operating on the lung, esophagus, diaphragm, airway, pleaura, mediastinum, and chest wall.





The book is relevant to practicing surgeons, surgeons in training, as well as medical professionals working with thoracic diseases.
Preface.-
1. Introduction.-
2. Evidence based medicine: quality of
evidence and evaluation systems.-
3. Decision analytic techniques and other
decision processes.-
4. Decision Making: The Surgeons Perspective.-
5.
Involving Patients in Difficult Decisions about Having Surgery.- Part I.
ERAS.-
6. Does Early Postoperative Ambulation Improve Surgical Outcomes After
Lung Resection for Cancer?.-
7. Does reduction of postoperative opioid use
lessen opioid dependence after lung resection for cancer?.-
8. Does
carbohydrate loading improve outcomes after esophagectomy?.-
9. Is
Intraoperative Fluid Restriction Effective in Reducing Complications After
Esophagectomy?.-
10. Does Early Post-Operative Feeding Improve Outcomes After
Esophagectomy?.-
11. Does early postoperative ambulation improve surgical
outcomes after esophagectomy?.- Part II. Prehabilitation.-
12. Exercise
prehabilitation and lung resection.-
13. Nutritional prehabilitation and lung
resection.-
14. Prehabilitation before esophagectomy: what are the benefits
of exercise?.-
15. Nutritional prehabilitation and esophagectomy.-
16.
Exercise Prehabilitation and Radical Surgery for Pleural Mesothelioma.- Part
III. Lung.-
17. Reducing Surgical Morbidity After Lung Resection - Effects of
Smoking Cessation.-
18. High-tech intraoperative guided biopsy and robotic
bronchoscopy biopsy versus wedge resection for a suspicious peripheral
nodule.-
19. Which is the optimal platform for robotic-assisted diagnostic
bronchoscopy?.-
20. Dye vs Fiducial Marking for Targeted Sublobar and Wedge
Resection.-
21. Utility of MVO2 vs ventilatory efficiency (VE/VCO2) in
assessing lung resection risk.-
22. Optimal Timing of Early-stage Lung Cancer
Resection.-
23. Can wedge resection supplant segmentectomy for small
peripheral NSCLC?.-
24. Does vein first hilar division improve survival after
lung cancer resection?.-
25. Segmentectomy versus Lobectomy in Patients with
Good Pulmonary Function - Oncologic Outcomes.-
26. Should pulmonary function
evaluation be repeated after induction therapy for lung cancer prior to
resection?.-
27. Does induction immunotherapy confer increased operative risk
for lung resection.-
28. Wedge Resection versus Stereotactic Body
Radiotherapy in Stage I Non-small Cell Lung Cancer.-
29. Salvage Resection
after Definitive Radiation Therapy for Stage I Non-Small Cell Lung Cancer.-
30. Is assessment of cDNA useful in surveillance after lung cancer
resection.- Part IV. Esophagus.-
31. Is mucosal eradication an effective
intervention for Barrett esophagus with dysplasia?.-
32. Do oral hygiene
interventions affect surgical outcomes after esophagectomy.-
33. Is
Measurement of Lung Function Helpful in Assessing Risk of Esophagectomy?.-
34. Preoperative Biomarkers in Gastro-oesophageal Adenocarcinoma.-
35.
Induction chemotherapy vs chemoradiotherapy for esophageal adenocarcinoma.-
36. Delayed surgical intervention after induction chemoradiotherapy for
esophageal cancer.-
37. Right vs left thoracic approach for esophageal
adenocarcinoma.-
38. Resection of 15 or more nodes improves survival in
esophageal cancer treatment.-
39. Organ sparing therapy for locally advanced
esophageal cancer.-
40. Can goals for early postoperative ambulation after
esophagectomy be established?.-
41. Is EndoFLIP helpful in individualizing
G-POEM for delayed gastric emptying after esophagectomy.-
42. Optimal Initial
Therapy for Achalasia.-
43. Are Stents Good Enough for Routine Initial
Therapy of Esophageal Perforation?.-
44. The utility of EndoFLIP in
individualizing POEM for achalasia.-
45. Peroral Endoscopic or Open Myotomy
for Zenkers Diverticulum.- Part V. Mediastinum.-
46. Does MRI contribute to
the accuracy of thymoma diagnosis?.-
47. Thymectomy in the setting of
synchronous pleural metastases.-
48. Pleural Metastasectomy for Regionally
Disseminated Recurrence of Thymoma.-
49. Controversies in Cardiac Sympathetic
Denervation for Ventricular Arrhythmias.- Part VI. Pleura.-
50. Is tPA/DNase
effective routine initial therapy for pleural empyema?.-
51. Indwelling
pleural catheter combined with chemical pleurodesis for the treatment of
malignant pleural effusion.-
52. Survival: Pleural Resection vs Nonsurgical
Management of Pleural Mesothelioma.- Part VII. Airway.-
53. Are bronchoscopic
techniques sufficient for managing posttransplant bronchial stenosis?.-
54.
Optimal Surgical Approach to Tracheobronchoplasty.- Part VIII. Diaphragm.-
55. Temporary Diaphragm Pacing for ICU Patients at Risk for Long-Term
Ventilation.-
56. Optimal technique of phrenic nerve reconstruction for
diaphragm paralysis.-
57. "The utility of paradoxical motion in selecting
patients for diaphragm plication".-
58. Diaphragm Paralysis: An Open vs.
Minimally Invasive Approach.- Part IX. Chest wall.-
59. Regional vs
intercostal blocks for minimally invasive thoracic surgery.-
60. Optimal
Duration of Nuss Bar Implant for Pectus Deformities.-
61. Intrathoracic or
Extrathoracic Fixation of Rib Fractures.- Part X. Complementary medicine.-
62. A Survey of Perioperative Applications of Traditional Chinese Medicine.
Mark K. Ferguson, MD, is Professor of Surgery at University of Chicago. He specializes in the surgical management of diseases of the chest. His most active areas of surgical management include lung cancer, benign and malignant esophageal diseases, mesothelioma, and thymoma.





Dr. Ferguson is the author of more than 120 chapters in medical textbooks. He has edited or written 10 books, and has completed 4 previous editions of Difficult Decisions in Thoracic Surgery. He is the editor for Difficult Decisions in Surgery, a series of books highlighting decision making in a variety of surgical subspecialties. He has also published more than 350 papers and abstracts in medical journals. Dr. Ferguson has a cumulative experience of more than 60 years in serving as a journal editor or deputy editor.





Among his research interests are risk analysis, long-term outcomes after cancer resection, development of simulation methods for surgical training, advanced techniques in surgical education, and factors that influence medical decision making including gender and racial/ethnic bias.   His more recent areas of focus include diagnosis and mitigation of frailty, the use of traditional Chinese medicine in managing oncology patients, and the interface of artificial intelligence (AI) with thoracic surgery.  His educational background includes an undergraduate degree from Harvard College and an MD degree from The University of Chicago. His surgical training and fellowship in medical education took place at The University of Chicago.